Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001852950-22-000001
Filing Date
2022-10-13
Accepted
2022-10-13 16:34:48
Documents
1
Effectiveness Date
2022-10-13
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10046
  Complete submission text file 0001852950-22-000001.txt   11103
Mailing Address 11099 NORTH TORREY PINES ROAD, STE. 290 LA JOLLA CA 92037
Business Address 11099 NORTH TORREY PINES ROAD, STE. 290 LA JOLLA CA 92037 858-348-2180
Enlaza Therapeutics, Inc. (Filer) CIK: 0001852950 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-461688 | Film No.: 221309380